Crossmark

ACTA1 is inhibited by PAX3-FOXO1 through RhoA-MKL1-SRF signaling pathway and impairs cell proliferation, migration and tumor growth in Alveolar Rhabdomyosarcoma

Crossref DOI link: https://doi.org/10.1186/s13578-021-00534-3

Published Online: 2021-01-28

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hu, Qiande

Zhu, Liang

Li, Yuan

Zhou, Jianjun

Xu, Jun
Funding

Funding for this research was provided by:

The National Natural Science Foundation of China grants (31471029, 31671055, 81461138037)

The expert work station (2017IC025)

The Shanghai Natural Science Foundation (15ZR1433900)

Shanghai East hospital project funds (DFQH-m6)
License Information

Text and Data Mining valid from 2021-01-28

Version of Record valid from 2021-01-28
More Information

Article History

Received: 23 August 2020

Accepted: 5 January 2021

First Online: 28 January 2021

Ethics approval and consent to participate

: The animal study was approved by the committee on the Ethics of Animal Experiments of Tongji University.

: Not applicable.

: The authors declare no potential conflicts of interest.

Document is current

Any future updates will be listed below